Investing

Johann Rupert’s investment giant on a roll

Remgro expects a significant bump in earnings for its 2025 financial year, as its investee companies outperformed.

Remgro, chaired by billionaire businessman Johann Rupert, is a South African-based investment holding company listed on the JSE.

The investment giant holds stakes in many of South Africa’s most well-known companies, including Mediclinic, RCL Foods, OUTsurance, and FirstRand.

On Wednesday, 10 September, Remgro released a trading statement for the year ended 30 June 2025.

In this statement, the company said it expects its headline earnings per share to increase by between 33% and 43% to between R13.54 and R14.56.

It explained that this growth was driven by improved operational performances from the majority of Remgro’s investee companies and lower finance costs.

In addition, these upcoming results benefited from a low comparative base, as Remgro’s 2024 financial year saw significant corporate actions that negatively impacted earnings.

Remgro’s full results for its 2025 financial year will be released on or about 23 September 2025.

These strong expected results come after Remgro recently received the green light from South Africa’s Competition Appeals Court for its deal with telecoms giant Vodacom.

The court recently approved Vodacom’s acquisition of a 30% to 34.95% stake in Remgro-owned Maziv, the parent company of Vumatel and Dark Fibre Africa.

While the deal is still subject to other approvals, the green light from the local competition watchdog marked a significant milestone in this three-year-long saga.

The companies first announced the transaction in November 2021, revealing that Vodacom had made an offer to buy a stake in CIVH’s fibre assets.

Remgro holds a 57% stake in Community Ventures Investment Holdings (CIVH), of which Maziv is a subsidiary. Maziv was established primarily to facilitate the transaction.

While initially struck down by the Competition Commission and then the Competition Tribunal, the companies believe this latest ruling, which set aside those rejections, is a positive sign that the deal will go through.

Newsletter

Comments